CaroGen Corporation has announced the electronic publication of a research article entitled “Virus-Like Vesicle-Based Therapeutic Vaccine Vectors for Chronic Hepatitis B Virus Infection.” The article appeared in the August online issue of the Journal of Virology.

“The publication of this work is a major milestone for CaroGen, as it provides a peer-reviewed report of our proof-of-concept HBV vaccine studies to date,” said Dr. Bijan Almassian, CEO of CaroGen.